Volunteers knit bra inserts for breast cancer survivors to dress well, regain confidence
Minister for Digital Development and Information Josephine Teo launching Knitted Knockers@NHG, where volunteers can knit and distribute the bra inserts, on June 6. ST PHOTO: TARYN NG
SINGAPORE - In her quest to find the right filling for her bra after undergoing mastectomy, breast cancer survivor Lyn Ee, 74, discovered Knitted Knockers, soft breast prostheses made from cotton yarn.
'They not only provide a gentler, softer alternative to the traditional breast prosthetics that can be hot and heavy, they also give back to breast cancer survivors their looks, confidence and peace of mind,' Ms Ee said.
Today, 10 years after her discovery , the soft mounds of cotton yarn are being distributed free at all restructured hospitals in Singapore to women who have had mastectomy.
Wanting to share her discovery of the prostheses with others here, Ms Ee in 2015 founded Knitted Knockers Singapore, t he local chapter of the American non-profit that has expanded internationally, gathering a group of volunteers to knit the bra inserts to give to breast cancer patients.
Knitted Knockers@NHG (National Healthcare Group), where volunteers can knit and distribute the bra inserts, was launched on June 6 by Minister for Digital Development and Information Josephine Teo.
Speaking at an event marking the 15th anniversary of the Tan Tock Seng Hospital (TTSH) Breast Clinic, Mrs Teo cited the initiative as an example of the good work the clinic has done.
'You want to provide the best clinical care and are equally keen to support the emotional well-being of your patients . The fact that you have put as priority helping patients regain a sense of normalcy and confidence – particularly for women who have had to go through mastectomies – is admirable ,' she said at the event.
Minister for Digital Development and Information Josephine Teo (right) greeting breast cancer survivor Lyn Ee.
ST PHOTO: TARYN NG
Mrs Teo also shared the story of Ms Carmelita Calesagsag, her family's foreign domestic helper of 27 years who is a breast cancer survivor.
The 61-year-old Filipina , fondly called Carmen by the Teos, has been working for the family for 27 years.
Mrs Teo said: 'I remember vividly the day she was diagnosed. After she had reported a lump, Carmen had been sent by our family doctor to be properly tested. Parliament was in session when I received Carmen's phone call. I guessed it was bad news, because she would otherwise have waited till I got home .
'Over the next few weeks, I saw her struggle with fear and despair. Against the advice of some, we decided she should be treated in Singapore instead of being sent home. Now, 17 years later, we are glad we made that choice. Carmen is fully recovered. She watched all three of our children become working adults and remains very much a part of our family.'
Ms Carmelita Calesagsag (right) has been working for Mrs Teo's family for 27 years.
PHOTO: COURTESY OF JOSEPHINE TEO
Breast cancer is the most prevalent cancer among women in Singapore, making up nearly 30 per cent of all cancers diagnosed among women here.
The incidence here has more than tripled over the past 50 years, to 74 cases per 100,000 women now – one of the highest in Asia.
The Breast Clinic has performed more than 6,100 breast cancer surgical operations since 2010 and over 450 in 2024 alone, the largest number within the NHG cluster last year .
One of the clinic's latest innovations is endoscopic breast surgery that combines keyhole mastectomy with immediate breast reconstruction.
The minimally invasive procedure is performed in the same setting by both a specially trained breast surgeon and a plastic surgeon. Cancerous tissue is removed from the affected breast, which is immediately reconstructed by the plastic surgeon using the patient's own skin, fat, and blood vessels.
Since its introduction at the clinic in November 2024, three of its patients have undergone this advanced dual procedure.
The first patient to undergo the procedure was polytechnic lecturer Kwa Sai Geok, 62, who was diagnosed with Stage 1 breast cancer during a routine mammogram in 2024.
Polytechnic lecturer Kwa Sai Geok was the first patient to undergo endoscopic breast surgery at the Tan Tock Seng Hospital Breast Clinic.
PHOTO: COURTESY OF KWA SAI GEOK
Describing herself as 'a forward-looking person and always trying my best to shorten the time to pull myself back up', Madam Kwa said she opted for the keyhole mastectomy and reconstructive breast surgery to future-proof her health.
'I did not feel any pain during the four-day stay in hospital... and life was back to normal about four months after my right hand fully recovered with the help of the TTSH physiotherapist,' she said.
Dr Ang Wei-Wen, a consultant from Breast Surgery Service at TTSH, said that not everyone is suitable for the minimal-scar endoscopic mastectomy and reconstructive surgery.
'This is due to various factors, such as the stage and type of cancer, the patient's overall health, and the location and size of the tumour,' he said.
Dr Ang said the next step would be to use robotics for the procedure.
'It is the future of breast surgery and already a trend in South Korea. It has more dexterity than a human surgeon, leading to smaller incisions, reduced pain, and faster recovery,' he added.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
16 hours ago
- Straits Times
Volunteers knit bra inserts for breast cancer survivors to dress well, regain confidence
Minister for Digital Development and Information Josephine Teo launching Knitted Knockers@NHG, where volunteers can knit and distribute the bra inserts, on June 6. ST PHOTO: TARYN NG SINGAPORE - In her quest to find the right filling for her bra after undergoing mastectomy, breast cancer survivor Lyn Ee, 74, discovered Knitted Knockers, soft breast prostheses made from cotton yarn. 'They not only provide a gentler, softer alternative to the traditional breast prosthetics that can be hot and heavy, they also give back to breast cancer survivors their looks, confidence and peace of mind,' Ms Ee said. Today, 10 years after her discovery , the soft mounds of cotton yarn are being distributed free at all restructured hospitals in Singapore to women who have had mastectomy. Wanting to share her discovery of the prostheses with others here, Ms Ee in 2015 founded Knitted Knockers Singapore, t he local chapter of the American non-profit that has expanded internationally, gathering a group of volunteers to knit the bra inserts to give to breast cancer patients. Knitted Knockers@NHG (National Healthcare Group), where volunteers can knit and distribute the bra inserts, was launched on June 6 by Minister for Digital Development and Information Josephine Teo. Speaking at an event marking the 15th anniversary of the Tan Tock Seng Hospital (TTSH) Breast Clinic, Mrs Teo cited the initiative as an example of the good work the clinic has done. 'You want to provide the best clinical care and are equally keen to support the emotional well-being of your patients . The fact that you have put as priority helping patients regain a sense of normalcy and confidence – particularly for women who have had to go through mastectomies – is admirable ,' she said at the event. Minister for Digital Development and Information Josephine Teo (right) greeting breast cancer survivor Lyn Ee. ST PHOTO: TARYN NG Mrs Teo also shared the story of Ms Carmelita Calesagsag, her family's foreign domestic helper of 27 years who is a breast cancer survivor. The 61-year-old Filipina , fondly called Carmen by the Teos, has been working for the family for 27 years. Mrs Teo said: 'I remember vividly the day she was diagnosed. After she had reported a lump, Carmen had been sent by our family doctor to be properly tested. Parliament was in session when I received Carmen's phone call. I guessed it was bad news, because she would otherwise have waited till I got home . 'Over the next few weeks, I saw her struggle with fear and despair. Against the advice of some, we decided she should be treated in Singapore instead of being sent home. Now, 17 years later, we are glad we made that choice. Carmen is fully recovered. She watched all three of our children become working adults and remains very much a part of our family.' Ms Carmelita Calesagsag (right) has been working for Mrs Teo's family for 27 years. PHOTO: COURTESY OF JOSEPHINE TEO Breast cancer is the most prevalent cancer among women in Singapore, making up nearly 30 per cent of all cancers diagnosed among women here. The incidence here has more than tripled over the past 50 years, to 74 cases per 100,000 women now – one of the highest in Asia. The Breast Clinic has performed more than 6,100 breast cancer surgical operations since 2010 and over 450 in 2024 alone, the largest number within the NHG cluster last year . One of the clinic's latest innovations is endoscopic breast surgery that combines keyhole mastectomy with immediate breast reconstruction. The minimally invasive procedure is performed in the same setting by both a specially trained breast surgeon and a plastic surgeon. Cancerous tissue is removed from the affected breast, which is immediately reconstructed by the plastic surgeon using the patient's own skin, fat, and blood vessels. Since its introduction at the clinic in November 2024, three of its patients have undergone this advanced dual procedure. The first patient to undergo the procedure was polytechnic lecturer Kwa Sai Geok, 62, who was diagnosed with Stage 1 breast cancer during a routine mammogram in 2024. Polytechnic lecturer Kwa Sai Geok was the first patient to undergo endoscopic breast surgery at the Tan Tock Seng Hospital Breast Clinic. PHOTO: COURTESY OF KWA SAI GEOK Describing herself as 'a forward-looking person and always trying my best to shorten the time to pull myself back up', Madam Kwa said she opted for the keyhole mastectomy and reconstructive breast surgery to future-proof her health. 'I did not feel any pain during the four-day stay in hospital... and life was back to normal about four months after my right hand fully recovered with the help of the TTSH physiotherapist,' she said. Dr Ang Wei-Wen, a consultant from Breast Surgery Service at TTSH, said that not everyone is suitable for the minimal-scar endoscopic mastectomy and reconstructive surgery. 'This is due to various factors, such as the stage and type of cancer, the patient's overall health, and the location and size of the tumour,' he said. Dr Ang said the next step would be to use robotics for the procedure. 'It is the future of breast surgery and already a trend in South Korea. It has more dexterity than a human surgeon, leading to smaller incisions, reduced pain, and faster recovery,' he added. Join ST's WhatsApp Channel and get the latest news and must-reads.
Straits Times
3 days ago
- Straits Times
Discovery of wartime bombs prompts large-scale evacuation in Cologne, Germany
BERLIN - Thousands of people were evacuated from central Cologne in western Germany on Wednesday following the discovery of three wartime bombs, in what the city authority called the largest such operation since the end of World War Two. An evacuation zone with a radius of 1,000 metres (1,100 yards) was cleared from 8 a.m. (0600 GMT), impacting around 20,500 residents along with many workers and hotel guests in the city's old town and Deutz district. Three American bombs, each with impact fuses, were found during construction work on Monday in Deutz, a bustling area on the bank of the River Rhine. Bomb disposal experts plan to disarm the ordnance later on Wednesday. Unexploded bombs are often found in Germany, where many major cities sustained heavy damage during the war. The evacuation area includes one hospital, two retirement homes, nine schools, and many hotels and museums. "Everyone involved hopes that the defusing can be completed in the course of Wednesday. This is only possible if all those affected leave their homes or workplaces early and stay outside the evacuation area from the outset on that day," the city authority said in a statement. The measures caused major transport disruptions in the city of over a million people, with Germany's national rail operator warning that many trains would be diverted or cancelled. A stretch of the Rhine will be blocked off before the bomb disposal operation begins. The Rhine, which runs from the Swiss Alps to the North Sea via Cologne, is one of Europe's key waterways for the transportation of commodities such as grain and coal. Private television station RTL, whose main office is located in the evacuation zone, interrupted its morning news programme. "We have to leave," the news anchor said, grabbing his bag as the lights were turned off. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
3 days ago
- Straits Times
From no hope to a potential cure for a deadly blood cancer
The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. PHOTO: UNSPLASH From no hope to a potential cure for a deadly blood cancer NEW YORK - A group of 97 patients had long-standing multiple myeloma, a common blood cancer that doctors consider incurable, and faced a certain, and extremely painful, death within about a year. They had gone through a series of treatments, each of which controlled their disease for a while. But then it came back, as it always does. They reached the stage where they had no more options and were facing hospice. They all got immunotherapy, in a study that was a last-ditch effort. A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients – a result never before seen in this disease. These results, in patients whose situation had seemed hopeless, has led some battle-worn American oncologists to dare to say the words 'potential cure.' 'In my 30 years in oncology, we haven't talked about curing myeloma,' said Dr Norman Sharpless, a former director of the National Cancer Institute who is now a professor of cancer policy and innovation at the University of North Carolina School of Medicine. 'This is the first time we are really talking seriously about cure in one of the worst malignancies imaginable.' The new study, reported on June 3 at the annual conference of the American Society of Clinical Oncology and published in The Journal of Clinical Oncology, was funded by Johnson & Johnson, which has an exclusive licensing agreement with Legend Biotech. The 36,000 Americans who develop multiple myeloma each year face an illness that eats away at bones, so it looks as if holes have been punched out in them, said Dr Carl June, of the University of Pennsylvania. Bones collapse. Dr June has seen patients who lost 6 inches (15.24cm) in height. 'It's a horrible, horrible death,' Dr June said. 'Right now advanced myeloma is a death sentence.' (Dr June has immunotherapy patents that are owned by his university.) There have been treatment advances that increased median survival from two years to 10 over the past two decades. But no cures. Dr Peter Voorhees of the Atrium Health Levine Cancer Institute in North Carolina and the Wake Forest University School of Medicine, who is lead researcher for the newly published study, said patients usually go through treatment after treatment until, ultimately, the cancer prevails, developing resistance to every class of drug. They end up with nothing left to try. The Legend immunotherapy is a type known as CAR-T. It is delivered as an infusion of the patient's own white blood cells that have been removed and engineered to attack the cancer. The treatment has revolutionised prospects for patients with other types of blood cancer, like leukaemia. Making CAR-T cells, though, is an art, with so many possible variables that it can be hard to hit on one that works. And it can have severe side effects including a high fever, trouble breathing and infections. Patients can be hospitalised for weeks after receiving it. But Legend managed to develop one that works in multiple myeloma, defying sceptics. The Chinese company gained attention for its CAR-T eight years ago when it made extravagant claims, which were met by snickers from American researchers. Johnson & Johnson, though, was looking for a CAR-T to call its own. So, said Mr Mark Wildgust, an executive in the oncology section of the American drug giant, the company sent scientists and physicians to China to see if the claims were true. 'We went site by site to look at the results,' he said. The company was convinced. It initiated a collaboration with Legend and began testing the treatment in patients whose myeloma had overcome at least one standard treatment. Compared with patients who had standard treatment, those who had the immunotherapy lived longer without their disease progressing. The immunotherapy received regulatory approval in that limited setting and is sold under the brand name Carvykti. The study did not determine whether this difficult treatment saved lives. The new study took on a different challenge – helping patients at the end of the line after years of treatments. Their immune systems were worn down. They were, as oncologists said, 'heavily pretreated.' So even though CAR-T is designed to spur their immune systems to fight their cancer, it was not clear their immune systems were up to it. Oncologists say that even though most patients did not clear their cancer, having a third who did was remarkable. To see what the expected life span would be for these patients without the immunotherapy, Johnson & Johnson looked at data from patients in a registry who were like the ones in its study – they had failed every treatment. They lived about a year. For Ms Anne Stovell of New York, one of the study patients whose cancer disappeared, the result is almost too good to be true. She says she went through nine drugs to control her cancer after it was diagnosed in 2010, some of which had horrendous side effects. Each eventually failed. Taking the Legend CAR-T was difficult – she said she had spent nearly three weeks in the hospital. But since that treatment six years ago, she has no sign of cancer. She said it was still difficult for her to believe her myeloma is gone. A new ache – or an old one – can bring on the fear. 'There's that little seed of doubt,' she said. But in test after test, the cancer has not reappeared. 'It's a relief for me every year to get a bone marrow biopsy,' she said. Myeloma experts applauded the results. Like treatments for many other cancers, treatments for multiple myeloma come with a high price. The drugs are 'hideously expensive,' Dr June said, costing more than US$100,000 (S$129,143) a year. The total cost over the years can be millions of dollars, Dr June said, usually paid by insurers, 'and it doesn't even cure you.' CAR-T is expensive too. Carvykti's list price is US$555,310. But it is a one-time treatment. And, more important, the hope is that perhaps by giving it earlier in the course of the disease, it could cure patients early on. Johnson & Johnson is now testing that idea. Dr Kenneth Anderson, a myeloma expert at Dana-Farber Cancer Institute who was not involved with the study, said that if the treatment is used as a first-line treatment, 'cure is now our realistic expectation.' That, at least, is the hope, Dr Sharpless said. And for those like the patients in the new study who are living at least five years – so far – without disease, the outcome 'really is eye-popping,' Dr Sharpless said. 'That's getting to a point where you wonder if it will ever come back,' he added. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
